[Elevated D-dimer in patients with cardiovascular diseases free from thromboembolic complications: what is it associated with and what has to be done?]
Related Experiment Video
Updated: Jun 3, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Insights
Elevated D-dimer levels in cardiovascular disease (CVD) patients without thromboembolic complications are predicted by female gender, age over 68, acute inflammation, pulmonary hypertension, and decompensated chronic cardiac insufficiency (CCI). These factors are key for risk assessment in CVD management.
Area of Science:
- Cardiology
- Hematology
- Internal Medicine
Background:
- Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide.
- D-dimer is a degradation product of cross-linked fibrin, often elevated in thrombotic disorders.
- Understanding D-dimer elevation in CVD patients without overt thromboembolism is crucial for risk stratification.
Purpose of the Study:
- To identify factors associated with elevated D-dimer levels in patients diagnosed with cardiovascular diseases (CVD).
- To specifically investigate predictors in CVD patients without apparent thromboembolic complications.
Main Methods:
- Retrospective analysis of 1,000 cardiovascular disease (CVD) patient case histories.
- D-dimer levels measured using latex agglutination; normal upper limit set at 0.5 μg/ml.
- Univariate and multivariate analyses performed on 867 patients without manifest thromboembolic complications.
Main Results:
- 32% of CVD patients without apparent thromboembolic complications exhibited elevated D-dimer levels.
- Univariate analysis identified 14 associated parameters (e.g., female gender, age >68, chronic cardiac insufficiency).
- Multivariate analysis revealed independent predictors: female gender, age >68 years, acute inflammatory process, pulmonary hypertension, and decompensated chronic cardiac insufficiency (CCI).
Conclusions:
- Elevated D-dimer is prevalent in CVD patients even without visible thromboses.
- Female gender, advanced age, acute inflammation, pulmonary hypertension, and decompensated CCI are independent predictors of elevated D-dimer.
- These findings aid in identifying at-risk CVD patients requiring closer monitoring for thrombotic events.
Purpose:
To study the factors associated with an elevated content of D-dimer in patients diagnosed as having cardiovascular diseases (CVD) with no apparent thromboembolic complications.
Material And Methods:
A retrospective analysis of 1,000 case histories of patients (624 men and 376 women) aged from 19 to 93 years and undergoing treatment at the Institute of Cardiology named after A.L. Myasnikov in 2009. The sole criterion for inclusion into the study was the fact of hospitalization for any CVD and an altered content of D-dimer. The D-dimer levels were determined by latex agglutination using reagent kits «ST ALIATES® D-DF» (Diagnostica Stago). The upper limit of the normal distribution of the D-dimer amounted to 0.5 μg/ml.
Results:
Thromboembolic complications were encountered in 13% of patients. Search for increased D-dimer predictors was carried out amongst a total of 867 CVD patients with no manifest thromboembolic complications. The D-dimer levels ranged widely from 0.01 to 16.97 (median 0.32, interquartile range 0.20-0.63) mg/ml and exceeded the upper limit of the normal distribution in 32% of the patients. Based on the findings of the univariate analysis we selected 14 parameters with the level of significance P<0.05, associated with an elevated D-dimer content. These parameters included but were not limited to: female gender, age >68 years, a history of venous thromboembolic events, no cardiac angina, the presence of ciliary arrhythmia and functional class III-IV chronic cardiac insufficiency (CCI), decompensated CCI, the presence of a permanent artificial pacemaker, an acute inflammatory process, chronic obstructive pulmonary disease, active cancer, pulmonary hypertension, and dilatational cardiomyopathy. The subsequent multivariate analysis showed that female gender, age >68 years, an acute inflammatory process, pulmonary hypertension, and decompensated CCI were independent predictors of an elevated D-dimer level in patients with CVD without apparent thromboembolic complications.
Conclusions:
The D-dimer level exceeded the upper limit of the normal distribution in 32% of CVD patients without manifest thromboembolic complications. Independent predictors of elevated D-dimer in CVD patients with no visible thromboses are as follows: female gender, age >68 years, acute inflammation, pulmonary hypertension, and decompensation of CCI.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
